Raymond James Financial cut shares of Oscar Health (NYSE:OSCR – Free Report) from an outperform rating to a market perform rating in a report released on Tuesday, MarketBeat reports.
OSCR has been the subject of a number of other research reports. Wall Street Zen cut shares of Oscar Health from a “buy” rating to a “hold” rating in a research report on Sunday, June 8th. Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Finally, Piper Sandler lowered their price objective on Oscar Health from $25.00 to $18.00 and set an “overweight” rating for the company in a research report on Monday, June 9th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $16.50.
Check Out Our Latest Research Report on Oscar Health
Oscar Health Stock Performance
Oscar Health (NYSE:OSCR – Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The business had revenue of $3 billion during the quarter, compared to analysts’ expectations of $2.87 billion. During the same period in the prior year, the business earned $0.62 earnings per share. The company’s quarterly revenue was up 42.2% compared to the same quarter last year. As a group, equities research analysts expect that Oscar Health will post 0.69 earnings per share for the current fiscal year.
Insider Buying and Selling at Oscar Health
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now owns 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 25.11% of the stock is currently owned by corporate insiders.
Institutional Trading of Oscar Health
Institutional investors have recently modified their holdings of the stock. Jones Financial Companies Lllp boosted its stake in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares in the last quarter. Strs Ohio purchased a new stake in Oscar Health in the first quarter valued at approximately $30,000. Larson Financial Group LLC boosted its holdings in shares of Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock valued at $33,000 after acquiring an additional 2,512 shares during the period. CWM LLC grew its position in shares of Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after acquiring an additional 1,078 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Oscar Health by 484.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock valued at $45,000 after acquiring an additional 2,854 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
- Five stocks we like better than Oscar Health
- What Are Dividends? Buy the Best Dividend Stocks
- 3 Hot Trades for Insiders, But Are They Good Buys for Investors?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Why Qualcomm’s Latest Price Target Can’t Be Ignored
- Why is the Ex-Dividend Date Significant to Investors?
- Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.